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ABSTRACT

Hoggatt, William F. M.S.B.M.E., Purdue University, August, 2016. Development
of a Fluidic Mixing Nozzle for 3D Bioprinting. Major Professor: Sherry L. VoytikHarbin.

3D bioprinting is a relatively new and very promising field that uses
conventional 3D printing techniques and adapts them to print biological materials
that are suited for use with cells. These bioprinters can be used to print cells
encapsulated within biological "ink" (bio-ink) to create and customize complex
three-dimensional tissues and organs. Our work has focused on developing a
new bioprinter nozzle that addresses critical gaps with present-day bioprinters,
namely, the lack of standardized, physiologically-relevant biomaterials, and their
one nozzle per composition printing capacity. These shortcomings preclude
printing a range of cellular and biomaterial compositions (including gradients of
cells and matrix components) within a single tissue construct.
Type I collagen oligomers, a new soluble collagen subdomain that falls
between molecular and fibrillar size scales, are ideally suited for tissue
fabrication. This collagen formulation, which is produced according to an ASTM
voluntary consensus standard, i) exhibits rapid suprafibrillar self-assembly
yielding highly interconnected collagen-fibril matrices resembling those found in
the body's tissues, ii) supports cell encapsulation, and iii) allows customized,
multi-scale design across the broadest range of tissue architectures and physical
properties. These properties, along with its superior physiologic relevance,
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support the use of this biomaterial in the development of a bioprinting nozzle that
is able to address the key gaps in the field of 3D bioprinting.
After researching microfluidic mixing devices and current bioprinters, early
iterations of a 3D bioprinting nozzle were designed and machined to mix three
fundamental reagents required to form a broad array of collagen-fibril matrix
compositions, namely oligomeric type I collagen (oligomer), oligomer diluent
(diluent), and self-assembly reagent (S.A.R). The nozzle was designed to mix
specified proportions of these solutions using a combination of hydrodynamic
focusing and twisted channel mixing mechanisms before depositing the selfassembling collagen. Three syringe pumps were used to continuously drive
varying flow rates of the three reagents to the nozzle, which allowed for the
creation of a broad array of cell and matrix compositions, including fibril-density
gradients.
To validate nozzle performance, three experiments were conducted to
define dispensing volume accuracy and precision, mixing quality, and functional
performance of dispensed materials, including cells and matrix.
In summary, the integration of standardized self-assembling collagens with
this innovative fluidic mixer effectively minimizes the number of printing
reservoirs, employs a single dispensing nozzle, and most importantly supports
"on demand" fabrication of various tissue compositions. This advanced 3D
bioprinting technology, together with our mechanistic-based tissue engineering
design principles, is expected to support customized design and fabrication of
complex and scalable tissues for both research and medical applications.
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CHAPTER 1. INTRODUCTION

Objectives
What is the long-term goal?
The goal of this research was to develop a prototype three-dimensional (3D)
bioprinter fluidic mixing nozzle that accommodates i) standardized selfassembling collagens; and ii) facilitates on demand fabrication of tissue
constructs with a wide range of cell and matrix compositions, including gradients.
Based on this engineering design problem, the specific aims of this project were:
1. Design, build, and validate a prototype 3D bioprinting nozzle that
accommodates self-assembling oligomeric type I collagen as the
primary extracellular matrix (ECM) component, as well as cells.
Nozzle performance will be characterized and validated in terms of
i) dispensing accuracy over a range of volumes, flow rates, and
syringe sizes; ii) mixing quality; and iii) maintenance of functional
characteristics of delivered materials (i.e., structural-mechanical
properties of deposited self-assembled collagen and cell viability).
2. Demonstrate the ability of the prototype nozzle to fabricate a
collagen fibril density gradient.
This work represents significant progress in the area of 3D bioprinting for
two reasons. First, self-assembling oligomeric type I collagen, is ideally suited for
tissue fabrication, compared to currently used biomaterials, since it facilitates
encapsulation of cells within collagen-fibril microenvironments that more closely
resemble those found in native tissue
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Second, the proposed design supports on demand dispensing of a broad
range of cell and/or matrix composition and gradients from a single nozzle within
the same tissue construct. This is an improvement over conventional bioprinter
designs, which accommodate multiple reservoirs with a one-nozzle-one
composition dispensing capacity.
Background
3D bioprinting has evolved from a field of science fiction, to a practical field with
potential applications in wound care, in vitro pharmaceutical and chemical
testing, and organ transplantation (Murphy 2014). Bioprinting was first defined in
2004 at an international workshop as “the use of material transfer processes for
patterning and assembling biologically relevant materials–molecules, cells,
tissues, and biodegradable biomaterials– with a prescribed organization to
accomplish one or more biological functions” (Mironov 2006). More specifically,
the goal of 3D bioprinting is re-create multicellular tissues and organs de novo
(Mironov 2006). To date, great strides have been made to achieve this goal; such
as the creation of tissue with pre-made channels for blood vessel attachment and
human-scale, mechanically stable implants such as calvarial bone, cartilage and
skeletal muscle (Zhang 2013, Kang 2016). These implants, while still in the realm
of research in academia, provide visibility to what might be possible in future
years for industry.
These 3D bioprinted tissues, or “tissue constructs”, are becoming more
common with increased knowledge and accomplishments in the 3D tissue culture
field. The field of 3D tissue culture is also expanding due to its improved
physiologic relevance over conventional 2D cell culture (Rimann 2012). This shift
from 2D to 3D tissue culture has brought to light the importance of the ECM.
Specifically, how matrix stiffness, architecture, and ligand presentation affects
cells. In turn, this has increased the need for scientists to systematically control
and vary the properties of the ECM to induce a desired cell behavior (Mason
2013). As an additive manufacturing method, 3D bioprinting shows significant
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potential to address these fabrication needs for advanced design and
construction of complex and scalable living tissues.

Types of 3D Bioprinters
At present, there are three categories of 3D bioprinters, including inkjet, laser
induced forward transfer (LIFT), and microextrusion (Murphy 2014). Each of
these has its own advantages and disadvantages that make it well suited for
different bioprinting applications in tissue engineering.

Figure 1. The three different types of bioprinters currently used for 3D bioprinting. (a)
Inkjet bioprinters. (b) Microextrusion bioprinters. (c) Laser-Assisted Bioprinters. (Murphy
2014).

Inkjet Bioprinting
Inkjet bioprinters are very common; partly because in the early days of 3D
bioprinting, you could very easily modify commercially available inkjet printers to
print cells (Murphy 2014). The inkjet nozzle is used to place precise volumes of
cells suspended in a biomaterial that are stored in a modified ink cartridge, just
like the commercial inkjet printers. This, coupled with control over the x, y and zaxis, makes it possible for researchers to print droplets on the scale of pico-liters,
at speeds of up to 10,000 drops/second, to create layers of cells with very high
resolution (Murphy 2014). Researchers now use mostly thermal (Cui 2012) or
piezo (Saunders 2008) controlled nozzles to achieve these speeds and low
volumes.
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The advantages of this style of bioprinting is the high cell viability (>80%),
and high resolution (Horváth 2015). The disadvantages include the high
susceptibility of nozzle clogging during the print, and the low volume dispensed
per second when compared to other bioprinters (Ozbolat 2013). Because these
printers lack the ability to print milliliters of biomaterial per second, like
microextrusion printers, they are not typically used to create large tissue
constructs. However; these bioprinters have been used in applications such as
the creation of skin and cartilage (Skardal 2012, Cui 2012), where the total
volume of the tissue construct is low, and can be created by stacking twodimensional sheets of patterned cells.

Laser Induced Forward Transfer Bioprinting (LIFT)
LIFT 3D bioprinters are similar to inkjet bioprinters, but were made to overcome
nozzle clogging limitations (Duocastella 2007). The mechanism underlying LIFT
is arguably the most complicated of the three types being addressed, but a brief
summary should aid in understanding the advantages of this type of bioprinter.
LIFT requires three components: a laser, a ribbon, and a substrate
(Guillotin 2010). The ribbon is composed of a thin, transparent material, such as
quartz or glass, which has a thin film of metal such as gold or titanium coated on
one side. A thin layer of the biomaterial with encapsulated cells is applied to the
metal film, and this whole component is flipped upside-down so the cells are
facing down, and the side of the transparent material without a metal coating is
facing upwards. A pulsing laser is then directed onto the top side of the thin metal
layer, through the transparent material. The laser heats the metal to a plasma
state, and this causes a shockwave that expels the biomaterial directly under the
laser. The expelled biomaterial lands on the receptor substrate, which varies
depending on the study, but can be as simple as a glass slide for imaging
purposes (Guillemot 2010, Guillotin 2010).
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Surprisingly, the heating of metal to a plasma state has very little effect on
the cells or proteins (Guillotin 2010). LIFT bioprinters have cell viabilities on par
or exceeding that of inkjet bioprinters, often above 90% (Murphy 2014), and do
not suffer from clogging like inkjet bioprinters. LIFT bioprinters also operate at
speeds which are very comparable to inkjet bioprinters (Mézel 2010). The
droplets can be small enough to contain only one encapsulated cell (Duocastella
2007) or up to 5-7 encapsulated cells (Guillemot 2010). The issue with these
small droplet sizes is that when the droplets are patterned in an array of
individual droplets, they will evaporate. This challenge is overcome by the
addition of glycerol to many LIFT biomaterials. However, if the glycerol content
exceeds 10% v/v, it will compromise cell viability (Guillemot 2010). Another
limitation of this type of bioprinter is the inability to print large-scale tissue
constructs, much like inkjet bioprinters. LIFT has been used to create smaller
tissue constructs (on the order of mm) such as cardiac patches that were later
implanted into mice suffering from myocardial infarction (Gaebel 2011), and used
extensively to create two-dimensional cell patterns (Guillemot 2010, Guillotin
2010, Duocastella 2007).

Microextrusion Bioprinting
The main type of 3D bioprinter that will be focused on in this work is
microextrusion. The basis of microextrusion bioprinting is the same as extrusiondeposition 3D printers that have become popular with hobbyists and
professionals (Ozbolat 2016). The main difference is instead of depositing
plastic, the printer deposits a biocompatible material capable of cell
encapsulation.
Most microextrusion bioprinters work by holding the ECM biomaterial in a
reservoir in its liquid state. As such, biomaterials that undergo self-assembly, or a
fluid to gel transition are utilized. Pressure is applied to the reservoir, by either
pneumatic or mechanical-driven systems, which causes the biomaterial to flow
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out of the reservoir and through an extrusion nozzle (usually outfitted with a
syringe needle), as shown in Figure 1b. The nozzle deposits the biomaterial on
the stage, where it is then converted into its gel-like state, most commonly done
by means of photopolymerization (Kolesky 2014) or addition of an ionic
crosslinking solution (Ozbolat 2014). An x-y-z robotic gantry system positions the
extrusion nozzle over a platform where the tissue construct is created, point-bypoint or layer-by-layer.
Modifications to this design have resulted in 3D bioprinters with multiple
reservoirs and extrusion nozzles (Duan 2013, Smith 2004, Skardal 2010,
Schuurman 2010, Wüst 2010, Pati 2014), and specialized nozzles to create
complex geometries (Zhang 2013, 2015), shown in Figures 2a and 2b,
respectively. Advantages of this bioprinter technology include i) the ability to print
in high cell densities, ii) the ability to print large tissue constructs with moderate
complexity, and iii) ease of use. The disadvantages are decreased cell viability,
thought to be caused by the shear forces exerted on the cells in a viscous fluid,
compared to the other types of 3D bioprinting, and decreased resolution (Ozbolat
2013). Arguably the most impressive tissue constructs have come from
microextrusion bioprinters, such as the creation of human-scale, implantable
tissues, such as calvarial bone, that show new blood vessel formation and host
tissue integration 5 months after implantation (Kang 2016).
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Figure 2. Modifications made to conventional microextrusion bioprinters that a) add the
ability to print more than one bio-ink, and type of bio-ink, and b) allow for the printing of
hollow hydrogel tubes (Schuurman 2011, adapted from Zhang 2013).

Table 1. Summary of the main features of each type of bioprinter (Murphy 2014).

Type of

Resolution Cell Viability Printed Cell

Bioprinter
Inkjet

Applications

Densities
μm

>85%%

<106

Thin layer tissue
replacement and patches

LIFT

μm

>95%

<108

Thin layer tissue
replacement and patches

Microextrusion

mm

40-80%

High

Human-scale tissue
replacement

Bottom-up Versus Top-down Tissue Fabrication
These three types of bioprinters use two distinct methods to create tissue
constructs: top-down and bottom-up. Both inkjet and LIFT bioprinting use the
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bottom-up approach to create tissue constructs. This approach aims to mimic the
heterogeneity of the cells, matrix, and growth factors of in vivo tissues with high
spatial resolution (up to 1μm) printing of these components (Guillotin 2010).
Using this method, researchers can attempt to mimic the organization and spatial
distributions of various cell population, matrix components, and growth factor
within a tissue, with the hope that the engineered tissue construct will function
similarly to the target tissue. Using this method, researchers have been able to
deposit droplets of biomaterial encapsulated cells (1-10 cells/droplet) with micron
precision to create complex patterns, as demonstrated in Figure 3.

Figure 3. The precise deposition of cells in a specific pattern using the high resolution
capacity of a LIFT bioprinter a) before the addition of 1% w/v alginate, and b) after the
addition of alginate (Guillotin 2010).

In contrast, microextrusion bioprinting works by using the top-down
approach. Microextrusion bioprinters do not have as high of resolution as LIFT or
inkjet bioprinters, so they are unable to deposit cells and growth factors with the
same spatial control as the bottom-up bioprinters. Instead, they recapitulate the
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general shape and bulk mechanical properties of the tissue (such as stiffness),
and deposit fewer cell types that have the potential to later differentiate and
proliferate into a more heterogeneous cell population that more closely
resembles native tissue. (Ozbolat 2014). This method relies on having a
microenvironment that the cells can remodel, and a biomaterial that has the
mechanical properties that allow it to hold its shape. With this method,
researchers have been able to create tissue constructs that closely mimic the
shape and structure of complex tissues, as shown in Figure 4.

Figure 4. The deposition of individual high density cell spheroids to form a hollow,
branched tube (Norotte 2009).
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Gap in current 3D bioprinters
One gap in current microextrusion bioprinters is the inability to print
heterogeneous tissue constructs, that is tissues containing various cells and/or
matrix densities. The more complex microextrusion bioprinters have multiple
reservoirs for different cell types and different materials, but the density (or
concentration) of the biomaterial in all of the reservoirs is kept constant. As a
result, these bioprinters are unable to achieve continuous gradients in cellular
and/or matrix components as is found within natural tissues (e.g., skin, cartilage)
in vivo. Therefore, the need exists for a bioprinter that allows the user to control
and change the density of the matrix and/or cells within the same tissue
construct. This new level of control will allow for more complex tissue constructs
to be created, and more research to be done on the effects of heterogeneous
ECM concentration and stiffness within tissue.

Biomaterial properties
While each bioprinter type uses specific biomaterials and biomaterial formats as
their bio-ink, all biomaterials must fulfill three design criteria; i) biocompatibility, ii)
printability, and iii) physiologic relevance.
One main design criterion for 3D bioprinter biomaterials is biocompatibility.
The material that is printed will eventually serve as the ECM for the encapsulated
cells. Therefore, the cells must be able to survive and execute fundamental
behaviors, including proliferation, migration, differentiation, and morphogenesis.
When thinking about biocompatibility, it is also important to know if and how the
biomaterial will degrade. Biomaterial degradation mechanisms (cell-induced,
proteolytic degradation or hydrolysis), byproducts produced, and how to control
the degradation rate are all important considerations (Murphy 2014). Degradation
of the biomaterial and deposition of ECM by resident cells affects the mechanical
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properties of the scaffold and some degradation products have been shown to
decrease cell viability (Hourd 2015, Lee 2016).
The second biomaterial design criterion is printability. Viscosity and
curing-time are the primary factors that determine printability. The material must
be viscous enough to hold its shape until the material converts into a more gellike state, or polymerizes. This polymerization can take anywhere from a few
seconds to a few minutes and is known as gelation-time (Murphy 2013). Many
materials do not initially have favorable printing properties, but in order to be
used for 3D bioprinting applications, they are modified with exogenous
crosslinking agents for photo-polymerization, chemical polymerization, or ionpolymerization (Suri 2011, Rutz 2015, Rodrigues 2012).
The final biomaterial property that must be considered is physiologic
relevance. Physiologic relevance describes the similarities of the biomaterial to
the native ECM within the tissue of interest. It is not enough for the cells to
survive in the biomaterial (biocompatibility). For the true potential of the cells to
be realized, they must be able to proliferate, migrate, differentiate, and remodel
the environment around them, as they would in vivo. Properties of physiologic
relevance include the presence of ligands that would normally be found in vivo, a
chemical structure of the biomaterial that closely resembles native tissue, and
matching stiffness and concentration of the native ECM. All of the current
biomaterials used in 3D bioprinting are evaluated against these three criteria.

Current biomaterials used in 3D bioprinting
Biomaterials used in 3D bioprinting can be divided into two categories: synthetic
or naturally-derived polymers (Murphy 2014).
Synthetic polymers are any polymeric biomaterial that is man-made. The
advantage of synthetic polymers is the ability to tune the chemical properties for
a specific application. Properties like mechanical stiffness, degradation rate, and
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porosity can all be controlled for the experiment (Kolesky 2014). The
disadvantages of synthetic polymers is the lack of physiologically-relevant
architecture and biological signaling capacity. For this reason, synthetic polymers
are often used in conjunction with naturally-derived polymers or functional motifs
(e.g., cellular binding domains) derived from these polymers. The naturallyderived polymer contains the cells, and is printed around a scaffold of synthetic
polymer that provides mechanical integrity. Examples of popular synthetic
biomaterials include polyethylene glycol (PEG), polycaprolactone (PCL), and
pluronic F127.
Naturally-derived biomaterials are derived from a natural source.
Naturally-derived biomaterials encompass both nature-derived and tissuederived biomaterials. Tissue-derived biomaterials are specifically derived from
animal tissue. The advantage of tissue-derived polymers is their biocompatibility
and physiologic relevance. In 3D bioprinting, these biomaterials are often used to
encapsulate cells. The disadvantages of these polymers include high lot-to-lot
variation, poor mechanical integrity and lack of tunability. Properties like stiffness,
porosity, degradation rate, and curing-time have historically not been controlled
or characterized, leading to poor reproducibility within and between laboratories.
To combat this, synthetic polymers are often used in the same tissue construct,
as previously stated. Nature-derived biomaterials are derived from materials
found in nature, but not animal tissue. These biomaterials often have similar
biocompatibility characteristics to tissue-derived biomaterials, but lack
physiologic relevance. Of the numerous nature-derived polymers used in 3D
bioprinting, there are three that make up the majority: sodium alginate, gelatin
methacrylate (GelMA), and type I collagen (Ozbolat 2016).

Sodium Alginate
Sodium alginate is arguably the most common biomaterial due to its wide
availability, mechanical properties, and favorable gelation properties. Sodium
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alginate is a nature-derived block copolymer that is typically harvested from
brown seaweed, and is composed of different ratios of two monomers: guluronic
acid and mannuronic acid, or G units and M units, respectively (Rowley 1999).
Two molecules of alginate bind together between G units when a di-valent or trivalent metal ion bonds to one strand of alginate, and a separate strand also
binds to the same ion, as shown in Figure 5. The resulting structure entraps the
ions similar to eggs in a carton, which results in the name “egg box” model
(Sachan 2009). The addition of these ions causes alginate to form a gel, and the
ability of alginate to undergo gelation with only the addition of ions, like Ca2+, as
well as rapid gelation time, makes it an attractive biomaterial to use for
bioprinting (Murphy 2013). However, because alginate is not found naturally in
the body, this biomaterial lacks the inherent biological signaling capacity found in
biomaterials derived from animal tissue. This means mammalian cells are unable
to degrade and modify the alginate because they lack the enzymes to cleave the
polymer chain (Lee 2012). Mammalian cells are also unable to interact with
alginate gels due to the discouragement of protein adsorption by the hydrophilic
nature of alginate (Rowley 1999).

Figure 5. Molecules of alginate being bound together in an “egg box” formation by the
addition of sodium ions (Lee 2012).

GelMA
Gelatin methacrylate is a very popular biomaterial that is advantageous for its
photo-polymerization and a microstructure that is more physiologically relevant
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than non-tissue derived biomaterials, such as alginate (Skardal 2014). Gelatin is
derived from the partial hydrolysis of collagen, the most abundant protein in the
ECM of animals (Gómez-Guillén 2011, Stenzel 1974). The partial hydrolysis of
collagen breaks down the triple helix molecular structure, but keeps many of the
arginine-glycine-aspartic acid sequences (RGDs) that promote cell attachment in
vivo. The hydrolysis also does not affect the regions of the protein that are
susceptible to degradation by matrix metalloproteinases (MMPs); the enzyme
used by mammalian cells to degrade and remodel the local ECM (Yue 2015).
When gelatin is cooled, there is an incomplete regain of the triple helix structure,
and the gelatin solidifies (Van Den Bulcke 2000). This leads to a biomaterial with
much greater physiologic relevance than synthetic or non-animal derived
biomaterials.
One of the major disadvantages with this material is its gelation.
Polymerization of gelatin without any additives is thermally reversible, and gels
will revert back to a liquid state at physiologic temperatures. One of the more
popular ways to stabilize the gel is to add methacrylic anhydride (MA), which
binds to the amine and hydroxyl groups of the gelatin, and causes the permanent
gelation of the combined materials (GelMA) upon exposure to UV light (Yue
2015), and in presence of a photoinitiator, as illustrated in Figure 6. The addition
of MA only affects 5% of the amino acid residues in molar ratio (a degree of
substitution, DS, of 5%), so it is thought that the vast majority of RGDs are still
available to interact with the cell (Van Den Bulcke 2000). Because of its photopolymerization capacity, GelMA has been used extensively to create very
complex and very small shapes that are much more easily made via the precise
application of UV light (Gauvin 2012).
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Figure 6. The polymerization of a) pure gelatin into helical structures, when temperature
(t) decreases, and subsequent dissociation when the temperature is increased; and b)
the polymerization of GelMA with a low degree of substitution (DS) in presence of UV
light, photoinitiator and decreased temperature, resulting in both helical bonds and
chemical crosslinks, and subsequent dissolution of the helical bonds upon heating
(adapted from Van Den Bulcke 2000).

Collagen Type I
Type I collagen is an abundantly used biomaterial in 3D bioprinting because of its
physiologic relevance and its ability to self-assemble in vitro and in vivo (Murphy
2013). The fundamental building block of collagen is tropocollagen, or
telocollagen, and consists of a triple helical structure, capped by short telopeptide
regions. These telopeptide regions participate in the self-assembly of
tropocollagen into microfibrils, which further assemble into fibrils in a fibrillar
matrix structure (Bailey 2011).
Monomeric collagen formulations, telocollagen and atelocollagen, have
traditionally been used as biomaterials for 3D bioprinting. However, these
formulations have been shown to suffer from variable purity and poor selfassembly capacity (Abraham 2008). Upon neutralization to physiologic pH and
ionic strength, monomeric collagen solutions self-assemble at the fibril level into
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entangled individual fibrils, as shown in Figure 7a, and because of the lack of
suprafibrilar assembly, the resulting matrix often suffers from poor mechanical
integrity and shape definition (Blum 2016). For monomeric collagen, gelation is
induced by increasing the temperature of neutralized solutions to physiologic
temperatures. This makes them an attractive biomaterial for the sake of
simplicity, but this polymerization process takes longer (typically 30 minutes or
greater) than many other biomaterials used in bioprinting. To compensate,
another biomaterial is often used to help collagen retain its shape (Chang 2011).
The benefit of monomeric collagen is that it self-assembles into a fibril format,
providing superior physiologic relevance when compared to almost all other
biomaterials. However; even though this biomaterial is more physiologically
relevant than many other popular biomaterials used in 3D bioprinting, there is still
a need for a better biomaterial.
Oligomeric collagen formulations are comprised of molecular aggregates
of telocollagen molecules (e.g., trimer) that uniquely retain their natural
intermolecular crosslinks (Bailey 2011). Compared to conventional collagen
monomers, oligomers exhibit more robust, rapid, and superior fibril-matrix
assembly, yielding highly interconnected collagen-fibril materials (Kreger et al.
2010, Bailey et al. 2011). Because oligomers exhibit both fibrillar and
suprafibrillar assembly, they support user customization and tunability across the
broadest range of fibril architectures and mechanical properties. Tuning fibril
density is achievable by controlling collagen concentration, as they are directly
related (Kreger et al. 2010). As shown in Figure 7b, the structure resulting from
the self-assembly of these molecules leads to matrices with suprafibrillar and
fibrillary organization. This, in turn, leads to decreased gelation time, increased
physiologic relevance, increased mechanical properties, and increased tunability
when compared to monomeric collagen. Oligomeric collagen is the only
formulation that is standardized (ASTM Standard F3089-14) and quality
controlled based upon its molecular composition and polymerization capacity,
providing the necessary reliability and reproducibility for 3D printing (ASTM
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F3089-14 2014).

Figure 7. Summary of the assembly of monomeric and oligomeric type I collagen both in
vivo and in vitro into fibril matrices (Blum 2016).

Gap in current biomaterials
There is one property of biomaterials used in 3D bioprinting that is consistently
overlooked: physiological relevance. Although type I collagen is the most
physiologically relevant biomaterial, as it is the most abundant protein in the ECM
of humans (Stenzel 1974), many 3D bioprinters modify its chemistry for better
printability or mechanical integrity. This is because most collagen used in 3D
bioprinting is poorly characterized, has uncontrollable gelling, and has poor
mechanical integrity (Jang 2016). What is needed is a type I collagen biomaterial
that is well characterized and mechanically stable, and a 3D bioprinter that is
able to take advantage of the superior tunability of this biomaterial.
Being able to easily modify the mechanical properties of a highly
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physiologically-relevant biomaterial, without the addition of exogenous chemicals,
would allow researchers to study tissue constructs that more closely recapitulate
the native in vivo tissue.

Recapitulation of Tissue and Organ Heterogeneity
All tissues are composed of cells and an ECM, organized to address specific
structural and functional demands of the tissue. Not only does tissue function
vary widely within the body, it also varies widely within tissues and organs
themselves. Because of this heterogeneity within tissues, complex architectures
such as gradients of cellular and ECM components are often found in vivo.
ECM stiffness and concentration differ greatly in the body (Justin 2011);
not only between different types of tissue, but also within tissues themselves
(Wells 2008). For instance, the stiffness of brain tissue is around several hundred
pascals (Pa), but the stiffness of muscle is more than 12 Kilopascals (kPa), and
the stiffness in the liver alone can range from 300 to 600 Pa in healthy tissue,
and up to 20 kPa in diseased tissue (Wells 2008). Continuous ECM stiffness
gradients are also found in the body, such as in the ligament-to-bone interface,
as shown in Figure 8, and in the deeper layers of skin (Justin 2011). This
knowledge has led to studies on the effect of ECM concentration, and stiffness
gradients in particular, on various cell types.
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Figure 8. Schematic of the tendon-to-bone interface (adapted from Seidi 2011).

The fact that ECM stiffness gradients affect cell function has been well
established (Shamloo 2010). Cells sense the change in ECM stiffness with
surface receptors known as integrins (Friedl 1998). Integrins on the surface of
cells bind to ligands in the ECM in order to move the cell during migration. The
activation of these receptors causes the regulation of many different pathways
within the cell, which cause various cell behaviors such as cell migration
(Georges 2005). However, many studies regarding the effect of ECM stiffness on
cell behavior have been done in 2D. This has been done to extricate confounding
variables that accompany increasing the stiffness of a 3D matrix, such as
decreased porosity and an increase in the number of ligand-adhesion points for
cells (Georges 2005). Considering the primary goal of these studies has been to
characterize the effect of ECM stiffness alone, removing confounding variables is
to be expected. These studies have also been performed exclusively in 2D due
to the lack of well characterized and tunable biomaterials that can be used for 3D
cell studies (Mason 2013, Gu 2016).
From 2D studies, ECM substrate stiffness has been shown to play a major
role in development (Justin 2011), cancer progression (Lu 2012), disease
progression (Wells 2008), neuron function (Balgude 2001), and stem cell
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differentiation (Justin 2011). While these studies show a clear effect of the
substrate stiffness on different cell functions, it is well known that the results
might not translate when performed in a 3D environment. Doing experiments
such as these in 3D matrices that are physiologically relevant is important to
increasing our understanding of how ECM concentration and stiffness affects
cells in vivo.
Fortunately, there have been in vitro studies in 3D cell cultures that prove
that ECM stiffness and concentration have similar effects on cells. For instance,
in the area of vasculogenesis, varying ECM stiffness causes morphological
changes in the resulting vascular network (Whittington 2013). Unlike 2D studies,
3D experiments are often not able to remove the confounding variables such as
variable ligand density, but they more closely recapitulate the in vivo cellular
microenvironment (Hadjipanayi 2009). A further benefit of performing ECM
concentration and stiffness experiments in 3D matrices is allowing users to
observe cellular phenomenon that only happen naturally in 3D, such as the
formation of a vacuole in vasculogenesis or angiogenesis.
It is clear that in order to have tissue constructs that recapitulate the ECM
found in vivo, there must be a focus on matching the heterogeneity of native
ECM concentration and stiffness. That is why I have proposed a novel 3D
bioprinting nozzle to address this issue.

Proposed 3D Bioprinter
The bioprinting nozzle was designed to accomplish the following goals:
1. Combine and mix the three reagents of oligomer, diluent, and
S.A.R continuously, over the course of printing the tissue construct.
2. Control the temperature of the fluids inside the nozzle
3. Print a wide range of collagen concentration from only the three
stock reagents, all within the same tissue construct.
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If the bioprinting nozzle accomplished all of these goals, it would be the first
3D bioprinter to use oligomeric type I collagen, and the first bioprinter to print a
tissue construct with a heterogeneous ECM concentration from a single
biomaterial. Not only would the system be able to print multiple concentrations of
collagen, and therefore different fibril densities, but it would be able to print a
broad range of concentrations, in a linear gradient.
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CHAPTER 2. MATERIALS AND METHODS

Design of the 3D Bioprinting Nozzle

Figure 9. Complete system diagram.

Design of the complete bioprinting nozzle, as shown in Figure 9, was broken into
four steps:
1. Chamber design, modeling, and fabrication
2. Solution dispensing
3. Graphical User Interface (GUI) development
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4. Evaluation and optimization of nozzle for printing self-assembling
collagen

Type I Oligomeric Collagen Preparation
Type I oligomeric collagen was acid-solubilized from the dermis of market weight
pigs and lyophilized for storage as described previously (Bailey 2011). According
to ASTM International standard F3089-14, the oligomeric formulation was
standardized on the basis of polymerization capacity and molecular composition
(ASTM F3089-14 2014). Polymerization capacity is defined by the shear storage
modulus G’, in Pa, as a function of oligomer concentration.

Design, Computational Modeling, and Fabrication of Mixing Chamber

Figure 10. CAD drawings of the designed mixing manifold from a top-down view, a); and
from an orthogonal view.

A mixing manifold was designed to achieve continuous mixing of three
fundamental reagents, oligomer, diluent, and S.A.R, needed to produce selfassembling collagen-fibril matrices over a broad range of microstructuremechanical properties, as shown in Figure 10. Other important design criteria
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included biocompatibility, chemical resistance, sterilizability, and adequate
thermal conductivity to facilitate temperature control.
The chamber was designed to include three channels (0.06” in diameter),
with the two outer channels offset from the central channel by an angle of 30
degrees. The diameter of the two outer channels narrowed to 0.03” as the two
outer channels intersected the central channel (Figure 11). According to Gobby
and co-workers, this angle of 30 degrees supports optimal mixing efficiency for
passive, microfluidic T-mixers (Gobby 2001). Narrowing of the outer two
channels was done to increase the velocity of the two outer streams of fluid
(Diluent and S.A.R) at the point of combination with the oligomer. Decreasing the
diameter of channels induces a venturi effect on the fluids, which was shown to
further increase the mixing efficiency in angled T-mixers (Gobby 2001). Holes for
three, 1/4-28 barbed fittings were added to the nozzle at the end of each channel
to allow for attachment of reagent lines.
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Figure 11. Schematic of the nozzle with dimensions of mixing chamber and channels for
reference.

Immediately following the intersection of the three channels, a mixing
chamber was added (0.093” in diameter) to ensure thorough mixture quality. To
aid in this, a disposable static mixer was placed in the mixing chamber (Nordson
EFD; East Providence, RI). Twisted channel mixing mechanisms induce complex
fluid dynamics, and are commonly added in mixing applications to increase the
mixing efficiency and mixture quality (Thakur 2003). For easy removal of the
static mixer, the mixing chamber was not made to fully house the static mixer, as
shown in Figure 12. The protruding end of the static mixer is housed in the
needle.
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Figure 12. Protruding end of the static mixer before the needle has been screwed into
place.

The needle was used to house the protruding end of the static mixer, and
to direct the flow of neutralized collagen onto the substrate. To minimize the
surface tension between the deposited collagen and the needle, the end of the
needle was machined into a cone. A small hole was machined into the coneshaped end (.0295” in diameter) to focus the deposition of collagen.

Computational Modeling
Computational modeling was performed to ascertain the value of narrowing the
outer channels before they intersected at the inner channel. Two 2D models of
the nozzle channels were constructed in a CAD program (Solidworks, Dassault
Systems) and imported into COMSOL Multiphysics 5.2. One model did not have
narrowed outer channels, and the other had channels narrowed to 0.03” in
diameter, directly before the intersection of the three channels. Laminar flow
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physics was selected, as initial calculations suggested the flow in the channels
would not reach turbulent levels.
Reynolds number was calculated using the following formula for pipe flow:
Reynolds Number =

𝑄𝐷
𝜈𝐴

Where 𝑄 is equal to the flow rate, 𝐷 is equal to the diameter of the pipe
(0.06” if not narrowed, and 0.03” if narrowed), 𝑣 is the kinematic viscosity, and 𝐴
being equal to the pipe cross-sectional area.
Flow rates at each inlet to the three inlet channels were estimated from
the conversion of expected 3D flow rates to 2D flow rates, and the average fluid
velocity was measured at the entrance to the mixing chamber. The average fluid
velocity was calculated by averaging the fluid flow velocity vectors along a
horizontal line extending from one side of the entrance to the mixing chamber to
the other. This vector was then converted into a magnitude and compared across
other fluid simulations. This was done for both narrowed and unchanged
diameter models. The materials in the models were varied between using water
as all three reagents, and having water as the reagents in the outer two
channels, and a material simulating the viscosity of the oligomer in the central
channel. Percent increase in fluid velocity was calculated by comparing the
average fluid velocities of two simulations using the same fluid and inlet
conditions, but different channel geometry.

Nozzle Fabrication
Fabrication of the main body of the nozzle was done by a separate company
(Wirecut Industries, Indianapolis, IN). The needle was fabricated in-house. Both
the main body of the nozzle and needle were manufactured out of 304 stainless
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steel. This metal exhibits acceptable biocompatibility properties, is autoclaveable,
and has excellent thermal conductivity.

Solution Dispensing
To control the concentration of printed collagen, the ratio of the flow rates of
oligomer and diluent were varied. Varying the ratio of flow rates of these two
reagents changed the final concentration of the neutralized collagen. Control of
solution dispensing was performed by three lead-screw driven syringe pumps
(New Era Syringe NE-500, Farmingdale, NY), independently controlled by a GUI
developed in-house.

GUI Development

Figure 13. Screenshot of the GUI developed in-house, to control the 3D bioprinting
system.

The GUI was developed in MATLAB (Mathworks, 2014), and the summarized
process of the user input is explained below:
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1. The user specifies which reagent is loaded in each syringe pump
2. The user selects what brand and size of syringe each reagent is in
3. The user inputs the collagen concentration of the oligomer
4. The user inputs the desired concentration of printed, neutralized
collagen that is to be dispensed from the printer
a. If the user requires a single concentration, input the same
concentration for both the initial concentration and final
concentration of printed collagen
b. If the user requires a linear gradient of collagen
concentration, input the desired initial concentration, and the
final concentration of the printed collagen
5. The user selects the total volume of collagen to be dispensed from
the nozzle

Evaluation and optimization of nozzle for printing self-assembling collagen
3D bioprinting nozzle performance was validated in terms of:
1. Separate reagent dispensed volume accuracy
2. Simultaneous reagent dispensed volume accuracy
3. Mixing quality
4. Viscoelastic properties of self-assembled collagen
5. Gradient formation
6. Cell viability
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Separate reagent dispensed volume accuracy
Dispensed volume accuracy was measured using one syringe pump and
dispensing either oligomer or water through the middle inlet channel or either of
the side inlet channels, respectively. Water was used an analog for the diluent
and the S.A.R, as their viscosities are similar.

Water was placed into a 10cc syringe (BD Biosciences; San Jose, CA)
and secured into the syringe pump. The outlet of the syringe was attached to a
side inlet port of the bioprinting nozzle using flexible tubing. Three samples of
water (n=3) were dispensed (50, 100, 500, and 1000 uL) at each flow rate (10, 50
and 100 uL/sec) and weighed (Sartorius BP 210D; Goettingen, Germany). After
completion, the 10cc syringe of water was replaced by a 20cc syringe of water,
and the process was repeated. Once it had been repeated with the larger
syringe, the entire experiment was conducted again with un-neutralized collagen
attached to the middle inlet port of the nozzle.

Simultaneous reagent dispensed volume accuracy
Three different fluorescent dyes, Rhodamine 110 (Sigma, St. Louis, MO),
Rhodamine 6G (Sigma), and Rhodamine B (Sigma) were added to the diluent
(0.4 mg/ml), oligomer (0.4 mg/ml), and S.A.R (0.2 mg/ml), respectively. Handmixed and printed reagents were all made to achieve final neutralized collagen
samples made from the dyed reagents. These samples were made at
concentrations of 1.34, 1.92, 2.36, 2.73 and 3.06 mg/mL. Fluorescence of the
hand-mixed and printed samples was measured in a spectroflourometer at
excitation/emission wavelengths of 496/520, 526/555, and 550/625 for
rhodamine 100, 6G and B, respectively (Spectramax i3x, Molecular Devices,
Sunnyvale, CA).
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Dispensed volume accuracy of each reagent was measured by comparing
the fluorescence values of printed and hand-mixed samples for corresponding
collagen concentrations. 400 μL of each concentration was hand-mixed using the
dyed reagents, and from that, three, 100 μL samples were plated into three wells
of a 96 well plate (Costar; Sigma), (n=3). For printed samples, 150 μL of each
concentration was printed from the nozzle, into a 1.5 mL Eppendorf tube.100 μL
of that was plated into a well of a 96 well plate. This process was repeated three
times (n=3). After three samples of each concentration had been plated, the plate
was placed in an incubator, held at 37 °C and 5% CO2 for ten minutes to allow for
complete polymerization of samples. This process was repeated three times
(N=3). After the final incubation, the fluorescence of all samples was measured
(Spectramax i3x; Molecular Devices, Sunnyvale, CA). Accuracy was determined
using the formula:

𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 = 100 −

|𝐴𝑐𝑐𝑒𝑝𝑡𝑒𝑑 − 𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙|
∗ 100%
𝐴𝑐𝑐𝑒𝑝𝑡𝑒𝑑

Where the accepted value corresponded to the value of the hand-mixed
samples and the experimental value corresponded to the value of the printed
sample for each reagent.
Precision was calculated using the following equation:

𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =

|𝜇 − 𝑠𝑛 |
∗ 100%
𝑠𝑛

Where µ was the average fluorescent intensity for each reagent, and 𝑠𝑛
was each individual fluorescent value.

Mixing Quality
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Mixing quality is defined as the coefficient of variation (Statiflo 2016). As such,
mixing quality was measured by the following formula:
𝐴𝑣𝑒𝑟𝑎𝑔𝑒
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝐷𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛
Where average was the mean of the nine fluorescent values of each
reagent of both hand-mixed or printed samples, and similarly, the standard
deviation of the nine fluorescent values.

Viscoelastic properties of self-assembled collagen
Batches of oligomeric collagen are subject to a quality control process, as
defined by the ASTM standard guidance document (ASTM F3089–14 2014). In
accordance with this document, quality control was done through rheometric
testing of the polymerization capacity of the collagen. Three printed collagen
samples were made at each of the aforementioned concentrations, and printed
directly onto the rheometer base (AR2000; TA Instruments, Newcastle, DE), (n =
3) at volumes of 950 µL. These samples were compared to the standard curve of
the batch of collagen the reagents were taken from, and their storage moduli
were compared to three hand-mixed samples as the gold standard with a
standard t-test analysis of means; significance was determined with α<0.05.

Gradient Formation
A custom polymerization chamber was fabricated for the polymerization of 3 mLs
of oligomeric collagen. The chamber was held under the nozzle and, as the
nozzle dispensed 3 mL of collagen concentration starting at .5 mg/mL and ending
at 4 mg/mL, was moved along its longer axis to facilitate gradient formation.
Afterwards, the collagen was placed inside an incubator held at 37°C and 5%
CO2 for 30 minutes, and the resulting structure was imaged using confocal
reflectance microscopy (Blum 2016). This imaging technique allowed the fibril

33

microstructure to be visualized, to qualitatively compare the relative fibril density
of different locations along the length of the structure.

Cell Viability
Cell viability was measured using 0.4% trypan blue cell viability assay (Strober
2001). Neonatal human dermal fibroblasts (Lonza; Mapleton, IL) were cultured in
Dulbecco’s modified Eagle’s Medium (DMEM; Sigma, St. Louis, MO) and
supplemented with 10% fetal bovine serum (FBS, Sigma), 100U/ml penicillin
(Gibco, Carlsbad, CA) and 100 μg/ml streptomycin (Gibco). Cells were
maintained in a humidified environment of 5% CO2 at 37°C over a period of two
weeks, and split at 90% confluence. Cells suspended in DMEM were placed in a
3cc syringe at a concentration of 5x105 cells/mL, and loaded into a syringe pump.
The syringe was attached to a side channel of the bioprinting nozzle via a flexible
rubber tube, and 500 uL of media and cells were deposited in a 48 well plate at
varying flow rates (1000, 100 and 10 uL/sec). 500 uL of fibroblasts in media was
taken from the stock solution, without being printed, for the negative control. This
experiment was repeated three times (n=3), and the cell viability was recorded.

Statistical Analysis

All measurements are reported as mean ± standard deviation. Statistical
analyses were performed with SAS v. 17 (SAS Institute, Cary, NC). To
determine differences among treatment groups, the general linear model
procedure (GLM) was used to conduct unbalanced analysis of variance (ANOVA)
and perform multiple comparisons of least squares means using the TukeyKramer method. For simultaneous reagent dispensed volume accuracy analysis,
a completely blocked three factor ANOVA was used to determine significant
effects of syringe size, reagent viscosity, flow rate, total volume programmed to
be dispensed, and their interactions (α = 0.05) on the actual volume dispensed
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by the nozzle. Differences were considered significantly different with the critical
global p value of 0.05.
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CHAPTER 3. RESULTS AND DISCUSSION

For the first step, it was necessary to quantitatively define mixing quality, as to
have appropriate design criteria for the quality of the mixed reagents. Mixture
quality was statistically defined as the mixture concentration’s coefficient of
variation (Vanarase 2010, Günther 2006, Dreher 2009). This can be thought of
as how evenly distributed the fluids are in the mixture. This is typically measured
by sampling the concentration of a dilute solution in multiple places in the
container it is stored in, and calculating the standard deviation between the
measured concentration values. A typical objective for high mixing quality is
between 0.01 and 0.05, which ensures complete homogeneity of the mixture
(Statiflo 2016).

Narrowing outer nozzle channels increased fluid velocity into the mixing
chamber
Reynolds number calculations returned a maximum value of 2.7 for the narrowed
channel design and 2.3 for the unchanged channel design at the inlet to the
mixing chamber, indicating that the fluid would not be in the turbulent range. This
initial finding prompted the need for additional mixing strategies and confirmed
the use of laminar flow for the channel flow simulations.
Modeling nozzle channel geometry of both narrowed and unchanged
channel diameters established that decreasing the outer channel diameter
increased fluid velocity of fluid entering the mixing chamber. The effect of
narrowing the channels can be seen visually in Figure 13, as the lighter color of
fluid indicates a higher fluid velocity. The average percent increase in fluid
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velocity between the narrowed channel design and unchanged channel design is
shown in Table 2.

Figure 14. COMSOL models showing the effect of narrowing the outer channels on fluid
velocity. Models were developed for A and B) Water flowing out of the nozzle at 10 μL/s,
C and D) Water flowing at 100 μL/s, E and F) oligomer in the central channel with water
in the outer channels at 10 μL/s, and G and H) oligomer in the central channel with water
in the outer channels at 100 μL/s.

Table 2. Average percent increase in fluid velocity in narrowed channel design
compared to unchanged channel design.
Unchanged Channels

Narrowed Channels

Percent
Increase

Expected 3D Flow Rate
at Outlet (µL/s)

10

100

10

100

(10 / 100) µL/s

Water

0.004513

0.04510

0.00536

0.05438

18.8 / 20.6

Oligomer

0.004453

0.04466

0.005342

0.05339

20.0 / 19.5

This data demonstrated the utility of decreasing the diameter of the outer
channels in order to increase the fluid velocity of fluid entering into the mixing
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chamber. Increased fluid velocity is beneficial in this instance, due to its positive
correlation with mixing quality (Gobby 2001).

Single reagent volume dispensing showed a significant flow rate and total
volume interaction effect
Statistical analysis of dispensed volume accuracy showed no significant effect of
changing the syringe volume size, but significant effect of the interaction between
flow rate and volume dispensed (α = 0.05), (Table 2). This significant interaction
effect can be seen as a trend in the raw data of both water and oligomer for
either syringe size (Figures 15a-15d). For the higher flow rates (500 and 1000
uL/sec), the accuracy of the dispensed volume is positively correlated with the
expected dispensing volume.
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Figure 15. Single reagent dispensed volume accuracy for water (A and C), and
Collagen (B and D) using 20cc (A and B) and 10cc (C and D) syringes.

While the viscosity or size of reagent reservoirs does not affect the
accuracy of the dispensed reagent volume, the accuracy does decrease as the
flow rate increases for the smaller volumes dispensed (50 and 100 uL). The
insignificance of fluid viscosity was most likely due to the choice of syringe
pumps. Lead-screw driven pumps were chosen for this initial design iteration
because they are able to maintain a constant flow rate over a much larger range
of viscosities than pneumatically-driven syringe pumps. Pneumatic pumps
require higher applied pressures to move higher-viscosity materials, as this
requires more force. Lead-screw driven pumps are able to maintain a very high
constant force, which facilitates more accurate fluid displacement over a broader
range of viscosities. Because there was no significant difference between syringe
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sizes, this indicates that this system could benefit from larger reagent reservoirs;
as this would lead to replacing empty syringe reservoirs less frequently.
The significant difference in the interaction effect points to an inherent
limitation of the pumping system. Lead-screw driven syringe pumps are not
designed for the precise dispensing of small volumes of fluids. These pumps are
designed to maintain a constant flow rate, usually on the order of uL/min, for
hours at a time. This was made apparent by the pumps range of programmable
dispensing time, from hours to tenths of seconds. Operating at the very lowest of
the range of dispensing times most likely lead to this dispensing volume
inaccuracy.

Table 3. Significance of each variable for both water and oligomer dispensed volume
accuracy experiments and the statistical difference between the fluids themselves. (p <
0.05 denotes statistical significance)
Fluid
Variable

Water
Syringe

Volume

Oligomer
Flow

Vol*

Syringe

Volume

Flow

Flow
p-value

0.33

< 0.05

< 0.05

< 0.05

Vol*

Fluid

Flow
0.21

< 0.05

< 0.05

< 0.05

Dispensed volume accuracy revealed inaccurate S.A.R delivery during
simultaneous reagent pumping

0.86
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Figure 16. Fluorescent values for each reagent in hand-mixed and printed
samples. Denotes significance (p < 0.05).

Table 4. p-values comparing fluorescent intensity of printed samples to hand-mixed
samples, for each reagent, and target stiffness. (p < 0.05 denotes statistical significance)
200

400

600

800

1000

Diluent

0.217

0.37

0.671

0.317

0.819

Oligomer

0.814

0.487

0.236

0.145

0.198

S.A.R

0.064

0.043*

0.006*

0.027*

0.02*

Both diluent and oligomer were able to be dispensed accurately (>90%);
however, the volume of S.A.R dispensed was significantly less than hand-mixed
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samples (Figure 16, Table 3). This could be explained by a limitation in the
pumping system. The total volume of S.A.R dispensed was much lower than that
of diluent or oligomer, and the pumping system was not designed to accurately
pump small volumes of fluid at high pressures for short durations (as seen in the
single regent volume accuracy data), and into other streams of pressurized fluid.
This could have resulted in the significant decrease in S.A.R delivery into the
final samples.
Table 5. Dispensed volume accuracy, precision and mixing quality for printed samples.
Diluent

Oligomer

S.A.R

Accuracy

94.50%

94.10%

53.20%

Precision

± 7.6%

± 5.1%

± 12.3%

Mixing Quality

0.1

0.07

0.17

The mixing quality and precision of printed samples were both lower than
that of hand-mixed samples (Table 5). Mixing quality of hand-mixed samples
were less than 5%, indicating a well-mixed fluid. This result partially validated the
experimental method, and was used as the gold standard. Mixing quality of the
printed samples was lower than that of hand-mixed samples. Furthermore, the
measured decrease in precision seen in printed samples indicated a need for a
more precise, reliable pumping system.
Table 6. Mixing Quality and Precision of printed samples compared to hand-mixed
samples.
Diluent

Oligomer

S.A.R

Mixing Quality

0.033

0.046

0.043

Precision

± 2.40%

± 3.40%

± 3.10%

Hand-Mixed
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Table 6 Continued.
Mixing Quality

0.1

0.07

0.17

Precision

± 7.60%

± 5.10%

± 12.30%

Printed

Shear storage modulus of printed samples are similar to hand-mixed
samples

Table 7. Shear storage modulus (G’) of hand-mixed and printed samples. * Indicates
significance (α < 0.05).
Target Stiffness

1000

800

600

400

200

Hand-Mixed

1109 ± 59*

861 ± 24

620 ± 29*

375 ± 49

199 ± 8.7*

Printed

703 ± 86*

698 ± 67

480 ± 44*

344 ± 48

171 ± 3.5*

(Pa)

Table 8. Statistical analysis of the difference between shear storage modulus of handmixed and printed samples.
Target Stiffness

1000

800

600

400

200

p-value

< 0.05

0.058

< 0.05

0.475

< 0.05

For all concentrations tested, the shear storage modulus of printed samples was
lower than that of hand-mixed samples (Table 6). The most likely cause for this
decrease in mechanical stiffness is the decrease in S.A.R dispensed in the
printed samples (Table 5). The S.A.R is responsible for the neutralization of the
final collagen sample. If the final pH of the collagen sample did not reach neutral
levels (due to a decrease in S.A.R in the mixture), this would have led to the
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incomplete polymerization of samples; thus, resulting in lower stiffness values. G’
of printed samples does approach hand-mixed and target values in the lower
stiffness range (200 – 400 Pa). This could be a result of interaction effects
between S.A.R and the flow of oligomer, which increases as the target stiffness
increases, possibly making it more difficult for the relatively small amount of
S.A.R to be dispensed properly.

The bioprinting nozzle is able to dispense a gradient of collagen
concentration within the same tissue construct
The microstructure of the 3 mL gradient tissue construct was analyzed using
reflectance imaging. The resulting fibril structures indicate that one end of the
tissue construct had a lower fibril density than the opposing side, and in between
the two extremes, a fibril density that is an average of the two, as shown in
Figure 17.

Figure 17. Tissue construct in fabricated well, with confocal reflectance images of the
collagen microstructure taken at three locations along the length.

Bioprinter mixing process does not affect cell viability
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Cell viability of printed cells in media was not significantly different than the
negative control (Figure 10). This indicates that the narrowing of the side
channel, mixing of the fluid in the mixing chamber, and final extrusion through the
needle, did not cause enough shear force to significantly affect the cell viability of
fibroblasts. Furthermore, there was no significant difference in cell viability
between cells dispensed at any of the tested flow rates, suggesting that flow rate
could be increased without having a deleterious effect on cell health. Increasing
the flow rate could be considered in later iterations of this design to increase
mixing quality.

Figure 18. Viability of cells printed at 10, 100, and 1000 μL/s compared to the positive
and negative controls. All experimental groups were statistically equivalent (p < 0.05).
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For this experiment, a 3cc syringe was used after the previous attempts of
using a 10cc syringe were done for 10 and 100 uL/sec resulted in low cell density
measured, as shown in table 9. After changing to the 3cc syringe, cell densities
improved.
Table 9. Average cell viabilities for each flow condition, the standard deviation, and the
statistical significance of the average cell viability of each flow condition compared to the
cells not dispensed through the mixer. (p < 0.05 denotes statistical significance)
Flow Condition
10 μL/s

100 μL/s

1000 μL/s

Starting Cell
Suspension

Cell Viability

80%

86%

75%

85%

Stdev.

4.2

3.5

5.1

4.3

p-value

0.373

0.78

0.224

-

Table 10. Cell density results for 10cc syringe and 3cc syringe sizes.
Syringe

10cc

3cc

Volume
Flow Rate

10

100

1000

10

100

1000

(μL/s)

Starting
Cell
Suspension

Cells / mL

85,926

58,889

-

408,148

476,296 440,740

450,370

The hypothesized reason for these low cell densities was cell settling in
the media. The syringe with cells in media was placed horizontally on the syringe
pump, and it was thought that after the time taken to calculate the cell viability of
three samples of printed solution, the remaining cells in the reservoir had sunk to
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the bottom edge of the syringe. When the next samples were dispensed from the
collagen, the majority of cells had settled to the bottom of the syringe, resulting in
decreased cell densities.
To overcome problems with cell settling, a 3cc syringe was used so that
after three samples had been printed and measured for cell viability, the stock
solution was mixed, and 2 mL was taken into the syringe and immediately
printed. This approach reduced the time that cells were in the reservoirs, and
resulted in higher cell densities, and more repeatable results.

47

CHAPTER 4. CONCLUSIONS AND FUTURE WORK

Implications for fluidic mixing 3D bioprinters
The experiments presented in this study have proven the potential for a fluidic
mixing nozzle that can dispense a broad range of ECM concentrations in a single
tissue construct. The mixing nozzle prototype was able to dispense accurate
volumes of two of the three reagents needed for oligomeric type I collagen during
simultaneous pumping, but dispensed significantly less S.A.R than was required.
The nozzle was found to create collagen samples that were similar to the
stiffness of hand-mixed samples, was able to print a gradient of collagen
concentrations in the same tissue construct, and was found to not significantly
decrease cell viability of printed fibroblasts.

Limitations needed to be addressed for the next prototype iteration
Limitations of the pumping system contributed to inaccurate volumes of
dispensed reagents, as seen directly from the dispensed volume accuracy data.
This effect was negated as much as possible by choosing a flow rate that had
been measured to be the most accurate during single reagent dispensing, but a
new pumping system that is designed for small volume fluid dispensing will need
to be procured for the next iteration of the mixing nozzle prototype.
Fluorescence data measured that the mixing quality of printed volume
fraction samples was less than those of hand-mixed samples, as well as
precision of reagent volume dispensed. This again raises the need for a pumping
system designed for this specific application. Mixing quality and precision should
increase with a pumping system that can dispense the correct volume of
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reagents during simultaneous dispensing. Increasing the flow rate of the
reagents would also improve mixing quality, but would need to be balanced by
the effect it would have on cell viability.
Final stiffness values of samples printed were lower than those of handmixed samples, and in conjunction with the reagent volume data, was explained
by the lack of S.A.R in printed samples. A more accurate pumping system and
would account for the differences seen between printed and hand-mixed volume
fraction samples for the rheometric experiment. Accurate pumping will ensure
that the correct amount of reagents are being dispensed, leading to the complete
neutralization.
The cell viability results suggested that this method of mixing and
combining fluids does not decrease cell viability significantly from cells not
extruded through the nozzle. Further experiments using cells encapsulated in
oligomeric collagen may provide a more relevant result regarding the cell viability
of cells printed in collagen, as this is the environment the cells would be
encapsulated in the mixing chamber and being extruded through the nozzle.

Future Work
The results presented in this thesis identify future design improvements and
experiment design that need to be completed to further the next prototype
design. Specific areas of investigation include 1) Improving the reagent pumping
system, 2) Reliable temperature control, 3) Direct quantification of fluidic mixing
quality and efficiency, and 4) More relevant cell viability studies. By addressing
these questions with specifically designed experiments, we can provide thorough
validation results for the next bioprinting nozzle, and build off of the key findings
from this research.
Firstly, a new pumping system should replace the current setup, as the
current setup was meant to serve as a proof-of-concept, and was never intended
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to be a final solution. The new pumping system should be designed to deliver
very small volumes of reagents against a high-pressure. Metering pumps or
similar systems might prove to be the best option for the next design of nozzle.
This will allow for the correct volumes of each reagent to be dispensed,
regardless of viscosity or flow rate of the other reagents being pumped into the
nozzle simultaneously, which is essential for this project.
Next, full control over the reagent temperatures is needed to ensure that
polymerization of the collagen does not occur in the nozzle. For this proof-ofconcept design, temperature control was accomplished with direct contact with
packs of ice, but this technique was difficult to manage, and constantly needed
maintenance. Full temperature control could be done by machining channels into
the nozzle that are pumped with chilled water- cooling the nozzle. Cooling of the
syringe reservoirs should also help ameliorate any foreseeable issue.
The direct quantification of fluidic mixing quality and efficiency is
paramount in the next version of the bioprinting nozzle. To do this, a new testing
method must be developed to directly, and more accurately, measure the mixing
quality and efficiency of each reagent. Using this test, optimization of flow rates
and mixing strategies could be undergone to achieve a desired mixing quality,
and improve mixing efficiency.
More relevant cell studies are needed to accurately predict the cell viability
of printed cells in oligomeric collagen. The current cell viability studies were done
with cell media, which has a much lower viscosity than the oligomeric collagen.
This difference in viscosity may result in differences in cell viability. Different cell
types should also be printed, as certain cell types are more sensitive to shear
forces.
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